News » MHRA alert » Torrent ramipril recall
February 14th 2024
Torrent Pharma (UK) Limited is recalling nine batches of ramipril 1.25mg tablets as a precautionary measure following post-marketing surveillance.
The affected batches are:
| Batch No | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| MG21264 | 29/02/2024 | 28 tablets | 13/12/2021 |
| MG21334 | 31/03/2024 | 28 tablets | 30/03/2022 |
| MG21335 | 31/03/2024 | 28 tablets | 26/05/2022 |
| MG221014 | 30/11/2025 | 28 tablets | 22/03/2023 |
| MG221016 | 30/11/2025 | 28 tablets | 16/05/2023 |
| MG23488 | 30/04/2026 | 28 tablets | 25/08/2023 |
| MG23489 | 30/04/2026 | 28 tablets | 12/09/2023 |
| MG23490 | 30/04/2026 | 28 tablets | 12/10/2023 |
| MG23729 | 30/04/2026 | 28 tablets | 05/12/2023 |
The precautionary measure is due to low assay and high related substances test results.
Dispensary teams are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process. Patients should continue to take medicines from these batches.
For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com
For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email: luke.davies@torrentpharma.co.uk or priti.pragji@torrentpharma.co.uk
